Cost-effectiveness of childhood rotavirus vaccination in Germany (Q42235703)

19 October 2017

title

Cost-effectiveness of childhood rotavirus vaccination in Germany (English)

1 reference

19 October 2017

0 references

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Markus Dietl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Juergen Wasem

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

6

Judith Koch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Pamela Aidelsburger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Kristin Grabein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Katharina Böhm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Bernhard Ultsch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Felix Weidemann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

20 February 2014

1 reference

19 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1964-1974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Intussusception and rotavirus vaccination: a review of the available evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Burden of rotavirus disease in European Union countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Impact of rotavirus vaccination on epidemiological dynamics in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Cost and cost-effectiveness of childhood vaccination against rotavirus in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.061

10.1016/J.VACCINE.2014.01.061

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json

release_aksqqkryxjcffbivfsif3g4tcq

7 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aksqqkryxjcffbivfsif3g4tcq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561052%20AND%20SRC:MED&resulttype=core&format=json